Lallemand Pharma

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Lallemand Pharma
Lallemand
  1. Lallemand Pharma
  2. A new bacterial lysate protects by reducing infectious exacerbations in moderate to very severe COPD

News details

Dec
12,
2016

A new bacterial lysate protects by reducing infectious exacerbations in moderate to very severe COPD

Dec 12, 2016

© 2024 Lallemand Inc. All right reserved